Literature DB >> 19789069

Diabetic painful and insensate neuropathy: pathogenesis and potential treatments.

Irina G Obrosova1.   

Abstract

Advanced peripheral diabetic neuropathy (PDN) is associated with elevated vibration and thermal perception thresholds that progress to sensory loss and degeneration of all fiber types in peripheral nerve. A considerable proportion of diabetic patients also describe abnormal sensations such as paresthesias, allodynia, hyperalgesia, and spontaneous pain. One or several manifestations of abnormal sensation and pain are described in all the diabetic rat and mouse models studied so far (i.e., streptozotocin-diabetic rats and mice, type 1 insulinopenic BB/Wor and type 2 hyperinsulinemic diabetic BBZDR/Wor rats, Zucker diabetic fatty rats, and nonobese diabetic, Akita, leptin- and leptin-receptor-deficient, and high-fat diet-fed mice). Such manifestations are 1) thermal hyperalgesia, an equivalent of a clinical phenomenon described in early PDN; 2) thermal hypoalgesia, typically present in advanced PDN; 3) mechanical hyperalgesia, an equivalent of pain on pressure in early PDN; 4) mechanical hypoalgesia, an equivalent to the loss of sensitivity to mechanical noxious stimuli in advanced PDN; 5) tactile allodynia, a painful perception of a light touch; and 5) formalin-induced hyperalgesia. Rats with short-term diabetes develop painful neuropathy, whereas those with longer-term diabetes and diabetic mice typically display manifestations of both painful and insensate neuropathy, or insensate neuropathy only. Animal studies using pharmacological and genetic approaches revealed important roles of increased aldose reductase, protein kinase C, and poly(ADP-ribose) polymerase activities, advanced glycation end-products and their receptors, oxidative-nitrosative stress, growth factor imbalances, and C-peptide deficiency in both painful and insensate neuropathy. This review describes recent achievements in studying the pathogenesis of diabetic neuropathic pain and sensory disorders in diabetic animal models and developing potential pathogenetic treatments.

Entities:  

Mesh:

Year:  2009        PMID: 19789069      PMCID: PMC5084286          DOI: 10.1016/j.nurt.2009.07.004

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  130 in total

1.  Safety and effectiveness of topiramate for the management of painful diabetic peripheral neuropathy in an open-label extension study.

Authors:  Peter D Donofrio; Philip Raskin; Norman R Rosenthal; David J Hewitt; Donna M Jordan; Jim Xiang; Aaron I Vinik
Journal:  Clin Ther       Date:  2005-09       Impact factor: 3.393

2.  Taurine replacement attenuates hyperalgesia and abnormal calcium signaling in sensory neurons of STZ-D rats.

Authors:  Fei Li; Irina G Obrosova; Omorodola Abatan; Dequan Tian; Dennis Larkin; Edward L Stuenkel; Martin J Stevens
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-01       Impact factor: 4.310

Review 3.  New and experimental approaches to treatment of diabetic foot ulcers: a comprehensive review of emerging treatment strategies.

Authors:  R Eldor; I Raz; A Ben Yehuda; A J M Boulton
Journal:  Diabet Med       Date:  2004-11       Impact factor: 4.359

4.  Treatment of Zucker diabetic fatty rats with AVE7688 improves vascular and neural dysfunction.

Authors:  C L Oltman; E P Davidson; L J Coppey; T L Kleinschmidt; M A Yorek
Journal:  Diabetes Obes Metab       Date:  2008-06-16       Impact factor: 6.577

5.  Antinociceptive effect of topiramate in models of acute pain and diabetic neuropathy in rodents.

Authors:  L S Lopes; S S Pereira; L L Silva; K A Figueiredo; B A Moura; F R C Almeida; F C F Sousa
Journal:  Life Sci       Date:  2008-11-17       Impact factor: 5.037

6.  Intraepidermal nerve fibers are indicators of small-fiber neuropathy in both diabetic and nondiabetic patients.

Authors:  Gary L Pittenger; Madhumita Ray; Niculina I Burcus; Patricia McNulty; Baher Basta; Aaron I Vinik
Journal:  Diabetes Care       Date:  2004-08       Impact factor: 19.112

7.  Melatonin reduces formalin-induced nociception and tactile allodynia in diabetic rats.

Authors:  Rosaura Arreola-Espino; Héctor Urquiza-Marín; Mónica Ambriz-Tututi; Claudia Ivonne Araiza-Saldaña; Nadia L Caram-Salas; Héctor I Rocha-González; Teresa Mixcoatl-Zecuatl; Vinicio Granados-Soto
Journal:  Eur J Pharmacol       Date:  2007-09-24       Impact factor: 4.432

8.  Is ACE inhibition with lisinopril helpful in diabetic neuropathy?

Authors:  A Reja; S Tesfaye; N D Harris; J D Ward
Journal:  Diabet Med       Date:  1995-04       Impact factor: 4.359

9.  A peroxynitrite decomposition catalyst counteracts sensory neuropathy in streptozotocin-diabetic mice.

Authors:  Viktor R Drel; Pal Pacher; Igor Vareniuk; Ivan Pavlov; Olga Ilnytska; Valeriy V Lyzogubov; Jyoti Tibrewala; John T Groves; Irina G Obrosova
Journal:  Eur J Pharmacol       Date:  2007-06-09       Impact factor: 4.432

10.  Allodynia and hyperalgesia in diabetic rats are mediated by GABA and depletion of spinal potassium-chloride co-transporters.

Authors:  Corinne G Jolivalt; Corinne A Lee; Khara M Ramos; Nigel A Calcutt
Journal:  Pain       Date:  2008-08-27       Impact factor: 6.961

View more
  98 in total

Review 1.  Role of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy.

Authors:  Megan Jack; Douglas Wright
Journal:  Transl Res       Date:  2012-01-10       Impact factor: 7.012

2.  Different roles of 12/15-lipoxygenase in diabetic large and small fiber peripheral and autonomic neuropathies.

Authors:  Irina G Obrosova; Roman Stavniichuk; Viktor R Drel; Hanna Shevalye; Igor Vareniuk; Jerry L Nadler; Robert E Schmidt
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

3.  Diet-induced obesity in Sprague-Dawley rats causes microvascular and neural dysfunction.

Authors:  Eric P Davidson; Lawrence J Coppey; Nigel A Calcutt; Christine L Oltman; Mark A Yorek
Journal:  Diabetes Metab Res Rev       Date:  2010-05       Impact factor: 4.876

Review 4.  Exercise as Therapy for Diabetic and Prediabetic Neuropathy.

Authors:  J Robinson Singleton; A Gordon Smith; Robin L Marcus
Journal:  Curr Diab Rep       Date:  2015-12       Impact factor: 4.810

5.  Malignant tumor formation after transplantation of short-term cultured bone marrow mesenchymal stem cells in experimental myocardial infarction and diabetic neuropathy.

Authors:  Jin-Ok Jeong; Ji Woong Han; Jin-Man Kim; Hyun-Jai Cho; Changwon Park; Namho Lee; Dong-Wook Kim; Young-Sup Yoon
Journal:  Circ Res       Date:  2011-04-14       Impact factor: 17.367

6.  Antinociceptive interaction of gabapentin with minocycline in murine diabetic neuropathy.

Authors:  H F Miranda; F Sierralta; V Jorquera; P Poblete; J C Prieto; V Noriega
Journal:  Inflammopharmacology       Date:  2017-02-28       Impact factor: 4.473

7.  Local sensory nerve control of skin blood flow during local warming in type 2 diabetes mellitus.

Authors:  Nicholas A Strom; Jessica R Sawyer; Shelly K Roberts; Shirley M Kingsley-Berg; Nisha Charkoudian
Journal:  J Appl Physiol (1985)       Date:  2009-12-03

8.  Skeletal Muscle Reflex-Induced Sympathetic Dysregulation and Sensitization of Muscle Afferents in Type 1 Diabetic Rats.

Authors:  Rie Ishizawa; Han-Kyul Kim; Norio Hotta; Gary A Iwamoto; Wanpen Vongpatanasin; Jere H Mitchell; Scott A Smith; Masaki Mizuno
Journal:  Hypertension       Date:  2020-02-17       Impact factor: 10.190

9.  NON-INVASIVE EVALUATION OF NERVE CONDUCTION IN SMALL DIAMETER FIBERS IN THE RAT.

Authors:  Elena G Zotova; Joseph C Arezzo
Journal:  Physiol J       Date:  2013

10.  High-fat diet-induced neuropathy of prediabetes and obesity: effect of PMI-5011, an ethanolic extract of Artemisia dracunculus L.

Authors:  Pierre Watcho; Roman Stavniichuk; David M Ribnicky; Ilya Raskin; Irina G Obrosova
Journal:  Mediators Inflamm       Date:  2010-04-08       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.